Kayla N Anderson1, Lakshmi Radhakrishnan2, Rashon I Lane3, Michael Sheppard2, Jourdan DeVies2,4, Roseric Azondekon2, Amanda R Smith2,5, Rebecca H Bitsko6, Kathleen P Hartnett2, Barbara Lopes-Cardozo7, Rebecca T Leeb6, Katharina L van Santen8, Kelly Carey2, Sophia Crossen9, Taylor P Dias10, Sam Wotiz10, Jennifer Adjemian2, Loren Rodgers2, Rashid Njai11, Craig Thomas3. 1. National Center for Injury Prevention and Control, US Centers for Disease Control and Prevention, Atlanta, Georgia. 2. Center for Surveillance, Epidemiology, and Laboratory Services, US Centers for Disease Control and Prevention, Atlanta, Georgia. 3. National Center for Chronic Disease Prevention and Health Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia. 4. Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee. 5. Epidemic Intelligence Service, US Centers for Disease Control and Prevention, Atlanta, Georgia. 6. National Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, Georgia. 7. Center for Global Health, US Centers for Disease Control and Prevention, Atlanta, Georgia. 8. ICF International, Atlanta, Georgia. 9. InductiveHealth Informatics, Ottawa, Kansas. 10. Deloitte, Atlanta, Georgia. 11. Office of Minority Health and Health Equity, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Abstract
Importance: The COVID-19 pandemic has negatively affected adult mental health (MH), with racial and ethnic minoritized groups disproportionately affected. Objective: To examine changes in adult MH-related emergency department (ED) visits into the Delta variant pandemic period and identify changes and inequities in these visits before and during COVID-19 case surges. Design, Setting, and Participants: This epidemiologic cross-sectional study used National Syndromic Surveillance Program data from US adults aged 18 to 64 years from 1970 to 2352 ED facilities from January 1, 2019, to August 14, 2021. All MH-related ED visits and visits related to 10 disorders (ie, anxiety, depressive, bipolar, schizophrenia spectrum, trauma- and stressor-related, attention-deficit/hyperactivity, disruptive behavioral and impulse, obsessive-compulsive, eating, and tic disorders) were identified. Exposures: The following periods of MH-related ED visits were compared: (1) high Delta variant circulation (July 18-August 14, 2021) with a pre-Delta period (April 18-May 15, 2021), (2) after a COVID-19 case peak (February 14-March 13, 2021) with during a peak (December 27, 2020-January 23, 2021), and (3) the Delta period and the period after a COVID-19 case peak with the respective corresponding weeks during the prepandemic period. Main Outcomes and Measures: ED visits for 10 mental disorders and all MH-related visits. Results: This cross-sectional study included 107 761 319 ED visits among adults aged 18 to 64 years (59 870 475 [56%] women) from January 1, 2019, to August 14, 2021. There was stability in most MH-related ED visit counts between the Delta and pre-Delta periods (percentage change, -1.4% to -7.5%), except for eating disorders (-11.9%) and tic disorders (-19.8%) and after a COVID-19 case peak compared with during a peak (0.6%-7.4%). Most MH-related ED visit counts declined in the Delta period relative to the prepandemic period (-6.4% to -30.7%); there were fluctuations by disorder when comparing after a COVID-19 case peak with the corresponding prepandemic period (-15.4% to 11.3%). Accounting for ED visit volume, MH-related ED visits were a smaller proportion of visits in the Delta period compared with the pre-Delta period (visit ratio, 0.86; 95% CI, 0.85-0.86) and prepandemic period (visit ratio, 0.80; 95% CI, 0.79-0.80). After a COVID-19 case peak, MH-related ED visits were a larger proportion of ED visits compared with during a peak (visit ratio, 1.04; 95% CI, 1.03-1.04) and the corresponding prepandemic period (visit ratio, 1.11; 95% CI, 1.11-1.12). Of the 2 510 744 ED visits included in the race and ethnicity analysis, 24 592 (1%) were American Indian or Alaska Native persons, 33 697 (1%) were Asian persons, 494 198 (20%) were Black persons, 389 740 (16%) were Hispanic persons, 5000 (0.2%) were Native Hawaiian or Other Pacific Islander persons, and 1 172 683 (47%) were White persons. There was between- and within-group variation in ED visits by race and ethnicity and increases in selected disorders after COVID-19 peaks for adults aged 18 to 24 years. Conclusions and Relevance: Results of this cross-sectional study suggest that EDs may have increases in MH-related visits after COVID-19 surges, specifically for young adults and individual racial and ethnic minoritized subpopulations. Public health practitioners should consider subpopulation-specific messaging and programmatic strategies that address differences in MH needs, particularly for those historically marginalized.
Importance: The COVID-19 pandemic has negatively affected adult mental health (MH), with racial and ethnic minoritized groups disproportionately affected. Objective: To examine changes in adult MH-related emergency department (ED) visits into the Delta variant pandemic period and identify changes and inequities in these visits before and during COVID-19 case surges. Design, Setting, and Participants: This epidemiologic cross-sectional study used National Syndromic Surveillance Program data from US adults aged 18 to 64 years from 1970 to 2352 ED facilities from January 1, 2019, to August 14, 2021. All MH-related ED visits and visits related to 10 disorders (ie, anxiety, depressive, bipolar, schizophrenia spectrum, trauma- and stressor-related, attention-deficit/hyperactivity, disruptive behavioral and impulse, obsessive-compulsive, eating, and tic disorders) were identified. Exposures: The following periods of MH-related ED visits were compared: (1) high Delta variant circulation (July 18-August 14, 2021) with a pre-Delta period (April 18-May 15, 2021), (2) after a COVID-19 case peak (February 14-March 13, 2021) with during a peak (December 27, 2020-January 23, 2021), and (3) the Delta period and the period after a COVID-19 case peak with the respective corresponding weeks during the prepandemic period. Main Outcomes and Measures: ED visits for 10 mental disorders and all MH-related visits. Results: This cross-sectional study included 107 761 319 ED visits among adults aged 18 to 64 years (59 870 475 [56%] women) from January 1, 2019, to August 14, 2021. There was stability in most MH-related ED visit counts between the Delta and pre-Delta periods (percentage change, -1.4% to -7.5%), except for eating disorders (-11.9%) and tic disorders (-19.8%) and after a COVID-19 case peak compared with during a peak (0.6%-7.4%). Most MH-related ED visit counts declined in the Delta period relative to the prepandemic period (-6.4% to -30.7%); there were fluctuations by disorder when comparing after a COVID-19 case peak with the corresponding prepandemic period (-15.4% to 11.3%). Accounting for ED visit volume, MH-related ED visits were a smaller proportion of visits in the Delta period compared with the pre-Delta period (visit ratio, 0.86; 95% CI, 0.85-0.86) and prepandemic period (visit ratio, 0.80; 95% CI, 0.79-0.80). After a COVID-19 case peak, MH-related ED visits were a larger proportion of ED visits compared with during a peak (visit ratio, 1.04; 95% CI, 1.03-1.04) and the corresponding prepandemic period (visit ratio, 1.11; 95% CI, 1.11-1.12). Of the 2 510 744 ED visits included in the race and ethnicity analysis, 24 592 (1%) were American Indian or Alaska Native persons, 33 697 (1%) were Asian persons, 494 198 (20%) were Black persons, 389 740 (16%) were Hispanic persons, 5000 (0.2%) were Native Hawaiian or Other Pacific Islander persons, and 1 172 683 (47%) were White persons. There was between- and within-group variation in ED visits by race and ethnicity and increases in selected disorders after COVID-19 peaks for adults aged 18 to 24 years. Conclusions and Relevance: Results of this cross-sectional study suggest that EDs may have increases in MH-related visits after COVID-19 surges, specifically for young adults and individual racial and ethnic minoritized subpopulations. Public health practitioners should consider subpopulation-specific messaging and programmatic strategies that address differences in MH needs, particularly for those historically marginalized.
Authors: Kristin M Holland; Christopher Jones; Alana M Vivolo-Kantor; Nimi Idaikkadar; Marissa Zwald; Brooke Hoots; Ellen Yard; Ashley D'Inverno; Elizabeth Swedo; May S Chen; Emiko Petrosky; Amy Board; Pedro Martinez; Deborah M Stone; Royal Law; Michael A Coletta; Jennifer Adjemian; Craig Thomas; Richard W Puddy; Georgina Peacock; Nicole F Dowling; Debra Houry Journal: JAMA Psychiatry Date: 2021-04-01 Impact factor: 21.596
Authors: Kathleen P Hartnett; Aaron Kite-Powell; Jourdan DeVies; Michael A Coletta; Tegan K Boehmer; Jennifer Adjemian; Adi V Gundlapalli Journal: MMWR Morb Mortal Wkly Rep Date: 2020-06-12 Impact factor: 17.586
Authors: Layla Parast; Megan Mathews; Steven Martino; William G Lehrman; Debra Stark; Marc N Elliott Journal: J Gen Intern Med Date: 2021-04-05 Impact factor: 5.128
Authors: Jonathan Henssler; Friederike Stock; Joris van Bohemen; Henrik Walter; Andreas Heinz; Lasse Brandt Journal: Eur Arch Psychiatry Clin Neurosci Date: 2020-10-06 Impact factor: 5.270
Authors: Mark É Czeisler; Kristy Marynak; Kristie E N Clarke; Zainab Salah; Iju Shakya; JoAnn M Thierry; Nida Ali; Hannah McMillan; Joshua F Wiley; Matthew D Weaver; Charles A Czeisler; Shantha M W Rajaratnam; Mark E Howard Journal: MMWR Morb Mortal Wkly Rep Date: 2020-09-11 Impact factor: 17.586
Authors: Jae Yong Yu; Feng Xie; Liu Nan; Sunyoung Yoon; Marcus Eng Hock Ong; Yih Yng Ng; Won Chul Cha Journal: Sci Rep Date: 2022-10-19 Impact factor: 4.996
Authors: Kyle Chankasingh; Amy Booth; Arianne Albert; Angela Kaida; Laurie W Smith; C Sarai Racey; Anna Gottschlich; Melanie C M Murray; Manish Sadarangani; Gina S Ogilvie; Liisa A M Galea; Lori A Brotto Journal: Heliyon Date: 2022-10-07